[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11201903834XA - Medical skin external preparation - Google Patents

Medical skin external preparation

Info

Publication number
SG11201903834XA
SG11201903834XA SG11201903834XA SG11201903834XA SG11201903834XA SG 11201903834X A SG11201903834X A SG 11201903834XA SG 11201903834X A SG11201903834X A SG 11201903834XA SG 11201903834X A SG11201903834X A SG 11201903834XA SG 11201903834X A SG11201903834X A SG 11201903834XA
Authority
SG
Singapore
Prior art keywords
external preparation
skin external
medical skin
medical
methyl
Prior art date
Application number
SG11201903834XA
Inventor
Tomoki Sakaguchi
Masumi Kawaguchi
Ayako Nakamura
Original Assignee
Maruho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Co Ltd filed Critical Maruho Co Ltd
Publication of SG11201903834XA publication Critical patent/SG11201903834XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

MEDICAL SKIN EXTERNAL PREPARATION An object of the present invention is mainly to provide a medical skin external preparation that is suitable for treating superficial skin infections, in particular, superficial skin infections accompanied by blister or erosion, etc. For example, the present invention can provide a medical skin external preparation containing - cyclopropy1-8-methyl-745-methyl-6-(methylamino)-3-pridyl]-4-oxo-1,4-dihydro-3- quinolinecarboxylic acid and/or a pharmaceutically acceptable salt thereof as an active ingredient, and an alcohol and/or a fatty acid having 12 or more carbon atoms. [no suitable figure] 24
SG11201903834XA 2016-12-01 2017-11-30 Medical skin external preparation SG11201903834XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016234508 2016-12-01
PCT/JP2017/043180 WO2018101443A1 (en) 2016-12-01 2017-11-30 Medical skin external preparation

Publications (1)

Publication Number Publication Date
SG11201903834XA true SG11201903834XA (en) 2019-05-30

Family

ID=62241709

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201903834XA SG11201903834XA (en) 2016-12-01 2017-11-30 Medical skin external preparation

Country Status (10)

Country Link
US (1) US11439634B2 (en)
EP (1) EP3549586A1 (en)
JP (1) JP6504728B2 (en)
KR (1) KR20190093562A (en)
CN (1) CN110035755A (en)
CA (1) CA3042980A1 (en)
MX (1) MX2019005372A (en)
PH (1) PH12019501206A1 (en)
SG (1) SG11201903834XA (en)
WO (1) WO2018101443A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020267406A1 (en) * 2019-05-06 2021-12-16 Spinart, LLC Formulations and methods for preparing stable cosmetic compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116020B2 (en) * 1987-05-20 1995-12-13 株式会社資生堂 Liquid crystal type external base
KR100550078B1 (en) 1998-04-06 2006-02-08 토야마 케미칼 컴퍼니 리미티드 Quinolonecarboxylic acid derivatives or salts thereof
JP4293755B2 (en) * 2001-03-26 2009-07-08 富山化学工業株式会社 External preparation for skin containing pyridonecarboxylic acid compound
JP2003012497A (en) * 2001-04-25 2003-01-15 Eisai Co Ltd Urea-containing composition for external use
JP4393552B2 (en) * 2005-08-01 2010-01-06 マルホ株式会社 Lotion containing a pyridonecarboxylic acid derivative
EP2177208A1 (en) * 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
CA2905587A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
EP3257512A4 (en) * 2015-02-13 2018-07-25 Maruho Co., Ltd. External preparation comprising pyridonecarboxylic acid derivative

Also Published As

Publication number Publication date
US11439634B2 (en) 2022-09-13
PH12019501206A1 (en) 2019-12-11
EP3549586A1 (en) 2019-10-09
WO2018101443A1 (en) 2018-06-07
CN110035755A (en) 2019-07-19
JPWO2018101443A1 (en) 2019-01-31
JP6504728B2 (en) 2019-04-24
US20190282562A1 (en) 2019-09-19
MX2019005372A (en) 2019-07-10
CA3042980A1 (en) 2018-06-07
KR20190093562A (en) 2019-08-09

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2020012595A (en) Topical pharmaceutical compositions.
MX2019005379A (en) Pyrazolo-heteroaryl derivative, preparation method and medical use thereof.
MX2016013529A (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
BR102016017090B8 (en) LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT
MY197785A (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
MY163235A (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
PH12016502103A1 (en) Novel disubstituted 1,2, 4-triazine compound
MY192033A (en) Method of dosing and use of soft anticholinergic esters
MX2022001697A (en) Pyrrolopyridine-aniline compounds for treatment of dermal disorders.
WO2016126085A3 (en) Heterocyclic compound and pharmaceutical composition comprising same
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
JOP20180071B1 (en) Use of aminoalkylbenzothiazepine derivatives
MX367321B (en) Skin care composition and method thereof.
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
MX2016016400A (en) Stabilized oxymetazoline formulations and their uses.
MX2016004909A (en) Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis.
MX2016008546A (en) Keloid reduction using topical allantoin.
SG11201903834XA (en) Medical skin external preparation
WO2014116015A3 (en) Composition for preventing alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt
MY197518A (en) Preventive and/or therapeutic agent of immune disease
MX2020007062A (en) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof.
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions